KOBAYASHI PHARMACEUTICAL Co., Ltd. (4967.T) — English Disclosures

KOBAYASHI PHARMACEUTICAL Co., Ltd. (4967.T) Prime Market English IR

All TDNet disclosures translated to English by Pulse News Wire.

Disclosures

Feb 3, 2026 — Mar 27, 2026

Date Range

PRIME

Market Segment

Chemicals

Sector

Disclosures

Date	Type	Headline	PDF
Mar 27	Other	Kobayashi Pharmaceutical TO REVIEW STOCK UNIT REDUCTION POLICY	PDF
Mar 3	Admin	KOBAYASHI PHARMACEUTICAL CO.,LTD. Announces Shareholder Meeting	PDF
Feb 18	Dividend	KOBAYASHI PHARMACEUTICAL CO.,LTD. Declares Dividend of 60 Per Share	PDF
Feb 18	Other	KOBAYASHI PHARMACEUTICAL CO.,LTD. Announces Amendment to Articles of Incorporation	PDF
Feb 10	Other	Kobayashi Pharmaceutical to Transition to Audit Committee Firm in March	PDF
Feb 10	Earnings	Kobayashi Pharmaceutical Co., Ltd. Reports FY25 Revenue of 166 billion, Up 0%	PDF
Feb 10	Dividend	KOBAYASHI PHARMACEUTICAL OUTLINES NEW THREE-YEAR BUSINESS PLAN	PDF
Feb 10	KPI	KOBAYASHI PHARMACEUTICAL Rejects Shareholder Proposals for Upcoming AGM	PDF
Feb 10	Other	KOBAYASHI PHARMACEUTICAL CO.,LTD. Announces Officer Appointments	PDF
Feb 10	Other	Kobayashi Pharmaceutical Updates Progress on Red Yeast Rice Incident Prevention Measures	PDF
Feb 3	Forecast	Earnings Forecast vs Actual Variance	PDF

Disclosure Types

Other: 5 Dividend: 2 Admin: 1 Earnings: 1 KPI: 1 Forecast: 1

Frequently Asked Questions

Where can I read KOBAYASHI PHARMACEUTICAL Co., Ltd.'s disclosures in English?

Pulse News Wire translates all TDNet filings for KOBAYASHI PHARMACEUTICAL Co., Ltd. (4967.T) to English. 11 disclosures have been translated since Feb 3, 2026.

How many disclosures has KOBAYASHI PHARMACEUTICAL Co., Ltd. filed on TDNet?

Pulse News Wire has translated 11 disclosures for KOBAYASHI PHARMACEUTICAL Co., Ltd. since Feb 3, 2026.

Does KOBAYASHI PHARMACEUTICAL Co., Ltd. publish English IR materials?

No. KOBAYASHI PHARMACEUTICAL Co., Ltd. is listed on the PRIME Market and has no English disclosure requirement. Pulse News Wire is the only English-language source for these filings.

What types of disclosures has KOBAYASHI PHARMACEUTICAL Co., Ltd. filed?

KOBAYASHI PHARMACEUTICAL Co., Ltd. has filed the following types of disclosures on TDNet: Other (5), Dividend (2), Admin (1), Earnings (1), KPI (1), Forecast (1).

English translations for all 4,436 JPX-listed companies.

Including the 2,300 Standard and Growth Market companies with no other English source.

See Pricing Browse Articles